Conference on Retroviruses and Opportunistic Infections (CROI 2020)
8 – 11 March 2020, Boston
We continue our coverage from CROI 2020 from March, which was run as a virtual conference.
All conference materials are now online.
Articles from the conference included in HTB are:
- Dolutegravir-based ART is safe and effective for pregnant women: first results from the VESTED trial